Jun 2, 2008
Paul Freiman
President and CEO, Neurobiological Technologies Inc. San Francisco Business Times Background: Freiman is guiding a company trying to turn the venom of the Malayan pit viper into a stroke treatment called ...
Comments
Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.
| Topic | Updated | Last By | Comments |
|---|---|---|---|
| Buck Institute, partner target Alzheimer's | Mar '08 | dan | 1 |

